JEANNETTE WADE; EDWIN WADE, Plaintiffs-Appellants,
v.
DANEK MEDICAL, INCORPORATED; SOFAMOR, INCORPORATED; SOFAMOR-DANEK GROUP, INCORPORATED; SOFAMOR, S.N.C.; WARSAW ORTHOPEDIC, INCORPORATED, Defendants-Appellees,
and
AMERICAN ACADEMY OF ORTHOPEDIC SURGEONS; NORTH AMERICAN SPINE SOCIETY; SCOLIOSIS RESEARCH SOCIETY; ZIMMER, INCORPORATED; DANEK CAPITAL CORPORATION; DANEK SALES CORPORATION; BUCKMAN COMPANY, INCORPORATED; NOREX USA, INCORPORATED; NATIONAL MEDICAL SPECIALTY, INCORPORATED; STUART, INCORPORATED; EDUARDO LUQUE; PAUL MCAFEE; ROGER P. JACKSON; DAVID BRADFORD; YVES COTREL; JEAN DUBOUSSET; HARRY SHUFFLEBARGER; R. GEOFFREY WILBER; CHARLES E. JOHNSTON, II; RICHARD ASHMAN, PH.D.; GARY LOWERY; GEORGE RAPP; ENSOR TRANSFELDT; HANSEN YUAN; JOHN A. HERRING; JOHN P. BARRETT; THOMAS WHITECLOUD, III; THOMAS A. ZDEBLICK; TEXAS SCOTTISH RITE HOSPITAL FOR CRIPPLED CHILDREN; GICD-USA; GROUPE INTERNATIONAL COTRELDUBOUSSET; ACROMED CORPORATION, CHARTER NUMBER 614043; ACROMED CORPORATION, CHARTER NUMBER 816942; ACROMED RESEARCH AND DEVELOPMENT CORPORATION; ACROMED SPINE RESEARCH FOUNDATION, INCORPORATED; ACROMED INCORPORATED, CHARTER NUMBER 811415; ACROMED INCORPORATED, CHARTER NUMBER 816943; ACROMED HOLDING CORPORATION, CHARTER NUMBER 811416; ACE MEDICAL COMPANY; ADVANCED SPINE FIXATION SYSTEMS, INCORPORATED; CROSS MEDICAL PRODUCTS; DEPUY-MOTECH, INCORPORATED; HOWMEDICA, INCORPORATED AND ITS PARENT PFIZER, INCORPORATED; SCIENTIFIC SPINAL; SMITH & NEPHEW RICHARDS, INCORPORATED; SYNTHES, U.S.A.; SYNTHES, Incorporated; SYNTHES NORTH AMERICA, INCORPORATED; SYNTHES, A.G. CHUR; ADVANCED BIOSEARCH ASSOCIATES; SPINAL SCIENCE ADVANCEMENT FOUNDATION; HEALTH INDUSTRY MANUFACTURER'S ASSOCIATION; ORTHOPEDIC SURGICAL MANUFACTURERS ASSOCIATION; SPINAL IMPLANT MANUFACTURERS GROUP; YOUNGWOOD MEDICAL SPECIALTIES, INCORPORATED; HANSEN YUAN, M.D.; RICHARD W. TREHARNE, Ph.D; ERMON R. PICKARD; STUART MEDICAL INCORPORATED, formerly known as Stuart Drug and Surgical Supply, Incorporated, Defendants.
No. 98-2036 (CA-95-876-3)
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
Argued: April 7, 1999
Decided: July 2, 1999
Amended: July 14, 1999
Appeal from the United States District Court for the Eastern District of Virginia, at Richmond. Richard L. Williams, Senior District Judge.[Copyrighted Material Omitted]
COUNSEL ARGUED: Thomas J. Byrne, CUMMINGS, CUMMINGS & DUDENHEFER, New Orleans, Louisiana, for Appellants. Gary Joseph Spahn, MAYS & VALENTINE, L.L.P., Richmond, Virginia, for Appellees. ON BRIEF: John J. Cummings, III, Frank C. Dudenhefer, Jr., CUMMINGS, CUMMINGS & DUDENHEFER, New Orleans, Louisiana; William C. Lane, MASSELLI & LANE, P.C., Arlington, Virginia, for Appellants. Dabney J. Carr, IV, MAYS & VALENTINE, L.L.P., Richmond, Virginia; George Lehner, PEPPER HAMILTON, L.L.P., Washington, D.C., for Appellees.
Before ERVIN, LUTTIG, and TRAXLER, Circuit Judges.
Affirmed by published opinion. Judge Luttig wrote the opinion, in which Judge Ervin and Judge Traxler joined.
OPINION
LUTTIG, Circuit Judge:
Jeannette and Edwin Wade appeal the district court's decision to grant summary judgment against them in this diversity action on the ground that the statute of limitations on their action was not equitably tolled during the pendency of federal class actions against some of the same defendants. Because we conclude that Virginia lacks an equitable tolling rule, and that Virginia law on equitable tolling would govern in this case, we affirm.
I.
In 1985, appellant Jeannette Wade began to experience back pain. In the following years, she underwent back surgery twice, but continued to suffer pain. Consequently, on October 26, 1992, Wade again underwent surgery, this time to fuse two vertebrae in her spine. During the course of that surgery, doctors implanted a pedicle screw spinal fixation device, manufactured by appellees Sofamor-Danek Group, Incorporated, and its subsidiaries (collectively "Danek"). The purpose of this device was essentially to act as an internal splint, thereby facilitating the fusion of the vertebrae. Although the use of the device for this purpose appears to have been common at the time of Wade's surgery, this use was not listed on the label for the device approved by the Food and Drug Administration.
The fusion surgery was a success; however, immediately after the surgery, Wade began experiencing worsened pain in her back and leg. She reported this pain to her doctors by no later than April 1993. In addition, Wade subsequently developed arachnoiditis, which is an inflammation of the membrane covering the spinal cord, and incontinence. After consulting with a number of doctors, Wade had the spinal fixation device removed on April 26, 1995.
Meanwhile, on December 30, 1993, a federal class action was filed in the United States District Court for the Eastern District of Pennsylvania against various pedicle screw spinal fixation device manufacturers, including Danek. See Zampirri v. AcroMed, No. CA-93-7074 (E.D. Pa. filed Dec. 30, 1993). On April 14, 1994, a similar class action was filed in the United States District Court for the Eastern District of Louisiana. See Brown v. AcroMed, No. 94-1236 (E.D. La. filed April 14, 1994). Wade and her husband, appellant Edwin Wade, were putative, but not named, class members in each of the actions. Pursuant to the multidistrict litigation statute, the Brown class action was transferred to the Eastern District of Pennsylvania, where it was consolidated with the Zampirri class action. On February 22, 1995, the district court denied class certification in Zampirri; on July 13, 1995, it did likewise in Brown.
On October 23, 1995, appellants filed this action in the United States District Court for the Eastern District of Virginia against Danek and a number of other manufacturers, individuals, and medical associations, alleging negligence, strict liability, conspiracy, and a host of other state law claims. The case was briefly transferred to the Eastern District of Pennsylvania, where the class actions had been consolidated, before being remanded to the Eastern District of Virginia. After the remand, defendants moved for summary judgment on the ground that Virginia's two-year statute of limitations had run. See Va. Code § 8.01-243(A) (1998). On May 13, 1998, the district court granted defendants' motions, rejecting plaintiffs' argument that the statute of limitations should be equitably tolled for the period during which the federal class actions were pending. See Wade v. Danek Med., Inc.,
II.
Appellants first contend that, even if the district court correctly concluded that the statute of limitations on their action should not be equitably tolled during the pendency of the federal class actions, the limitations period had nevertheless not lapsed by the time they filed their action.1 Appellants' primary argument is that, although Wade's initial injury -namely, her worsening pain -occurred immediately after the surgery, and therefore more than two years before their action was filed, Wade suffered a number of subsequent injuries -such as her incontinence -that did not arise until less than two years before their action was filed. This argument, however, is squarely foreclosed by Virginia law. In Virginia, "an injury is deemed to occur, and the statute of limitations period begins to run, whenever any injury, however slight, is caused by the negligent act, even though additional or more severe injury or damage may be subsequently sustained as a result of the negligent act." St. George v. Pariser,
Appellants briefly make two other points in support of their argument that the limitations period had not run on their right of action, neither of them availing. First, appellants contend that, because Wade had suffered similar back pain even before the implantation of the spinal fixation device, their right of action should accrue not at the time at which the device was implanted, but rather at the time at which the worsening of Wade's pain was specifically linked to the implantation of the device. It is well settled in Virginia, however, that the limitations period begins running at the time of the initial injury, not at the time of diagnosis or discovery. See Va. Code§ 8.01-230 (1998) (stating that limitations period runs "from the date the injury is sustained . . . and not when the resulting damage is discovered"); Locke v. Johns-Mansville Corp.,
Second, appellants contend, albeit baldly, that appellees failed to bear their burden of proving when Wade's injury occurred. In view of Wade's own admissions regarding the time at which her symptoms arose and the time at which she communicated them to her doctors, however, we agree with the district court that appellants amply met their burden of demonstrating when Wade's injury occurred "with a reasonable degree of medical certainty." Locke,
III.
Because appellants' action would otherwise be barred by Virginia's statute of limitations, we are squarely presented with the question whether the statute of limitations in appellants' action should be equitably tolled during the pendency of the Zampirri and Brown federal class actions. In answering this question, we must, because this is a diversity action, determine whether to look to federal or state law as a source for any equitable tolling rule.3 On the one hand, the Supreme Court has held that the statute of limitations in a subsequently filed federal question action should be equitably tolled during the pendency of a federal class action. See American Pipe and Constr. Co. v. Utah,
As a threshold matter, appellants contend that this apparent conflict between the federal and state rules on equitable tolling is illusory because the Virginia Supreme Court would apply an equitable tolling rule if presented with the issue. We disagree.
In predicting whether the Virginia Supreme Court would apply an equitable tolling rule, we are mindful of the general principle that, "[i]n trying to determine how the highest state court would interpret the law, we should not create or expand that State's public policy." Talkington v. Atria Reclamelucifers Fabrieken BV,
In the absence of any relevant Virginia law, we naturally look to the practices of other states in predicting how the Virginia Supreme Court would rule. A number of other states -some looking to the Supreme Court's decision in American Pipe-have adopted a rule allowing equitable tolling during the pendency of a class action in their own courts. See, e.g., First Baptist Church of Citronelle v. Citronelle-Mobile Gathering, Inc.,
This case, however, presents a slightly different question: namely, whether a state court would engage in equitable tolling during the pendency of a class action in another court -in this case, a federal court in another jurisdiction. Although a number of states have allowed equitable tolling for class actions in their own courts, only a very few have even addressed the question of "cross-jurisdictional" equitable tolling, much less allowed such tolling. See Portwood v. Ford Motor Co.,
Having considered these cases -most of which do not discuss the issue in any detail -we conclude that the Virginia Supreme Court would not adopt a cross-jurisdictional equitable tolling rule. First, and most importantly, the Commonwealth of Virginia simply has no interest, except perhaps out of comity, in furthering the efficiency and economy of the class action procedures of another jurisdiction, whether those of the federal courts or those of another state.7 Second, if Virginia were to adopt a cross-jurisdictional tolling rule, Virginia would be faced with a flood of subsequent filings once a class action in another forum is dismissed, as forum-shopping plaintiffs from across the country rush into the Virginia courts to take advantage of its cross-jurisdictional tolling rule, a rule that would be shared by only a few other states. See Portwood,
IV.
Having concluded that Virginia lacks an equitable tolling rule, and that the Virginia Supreme Court would not adopt such a rule, we are faced with a square conflict between the federal rule in favor of equitable tolling, on the one hand, and the state rule against equitable tolling, on the other. We therefore must determine whether we, as a federal court sitting in diversity, should resort to federal or state law on equitable tolling under Erie and its progeny. The Supreme Court has never directly addressed this question. However, not long after Erie, the Court held that, at least in cases (like this one) in which the choice of state or federal rule would be "outcome-determinative," it would look to state law in order to determine the governing statute of limitations. See Guaranty Trust Co. v. York,
Although the subsequent actions in Tomanio and Chardon were federal question actions, rather than diversity actions, we read those cases, together with Walker, to stand for the proposition that, in any case in which a state statute of limitations applies-whether because it is "borrowed" in a federal question action or because it applies under Erie in a diversity action -the state's accompanying rule regarding equitable tolling should also apply. Most of the other federal courts to have considered the issue in the diversity context have so ruled. See, e.g., "Agent Orange",
Appellants make two further arguments that the federal equitable tolling rule should apply in their case, both of which we reject. First, appellants contend that the federal equitable tolling rule established in American Pipe was based on, and thus implicitly inheres in, Rule 23, the federal rule governing class actions, and therefore that Rule 23 directly conflicts with, and thus trumps, any contrary Virginia rule against equitable tolling. See Hanna,
Second, appellants contend that the application of the federal equitable tolling rule is mandated by our prior decision in Atkins v. Schmutz Mfg. Co.,
In sum, we conclude that, under Erie and its progeny, Virginia's rule against equitable tolling, rather than the federal rule articulated in American Pipe, would apply in this case, and therefore affirm the district court's grant of summary judgment against appellants on the ground that the Virginia statute of limitations had run. CONCLUSION
The judgment of the district court is affirmed.
AFFIRMED
Notes:
Notes
At oral argument, counsel for appellants seemed to concede that the limitations period would have lapsed in the absence of an equitable tolling rule. Because appellants dispute this issue in their brief, however, we briefly address it here.
Virginia has enacted an exception to its general rule that the limitations period begins running at the time of injury in the specific context of product-liability actions involving recipients of breast implants, stating that the limitations period in those cases does not begin running until the recipient communicates her symptoms to her doctor. See Va. Code § 8.01-249.7 (1998).
At oral argument, and in its reply brief, counsel for appellants seemed to concede that state law would apply. Again, however, because appellants dispute this issue at some length in their original brief, we address it here.
Virginia does have a statute providing for tolling of the limitations period in certain other situations. See Va. Code § 8.01-229 (1998). Further, the Virginia Supreme Court has stated as follows: "In light of the policy that surrounds statutes of limitation, the bar of such statutes should not be lifted unless the legislature makes unmistakably clear that such is to occur in a given case. Where there exists any doubt, it should be resolved in favor of the operation of the statute of limitations." See Burns v. Board of Supervisors,
Illinois courts do allow intra-jurisdictional equitable tolling, however. See Steinberg v. Chicago Med. School,
Texas courts, too, have recognized intra-jurisdictional equitable tolling. See Grant v. Austin Bridge Constr. Co.,
Indeed, Virginia itself has no class action provision analogous to Federal Rule 23.
Of course, once a "protective" filing has been made, the state court could always stay proceedings in that action pending the resolution of the class action in the other jurisdiction, thus minimizing the effect of any duplicative litigation.
In addition, we believe that, even were the Virginia Supreme Court to adopt a cross-jurisdictional tolling more generally, it would not apply such a rule in a case such as this one, at least as against many of the defendants not named in this appeal, because the federal class actions did not place those defendants on sufficient notice of appellants' claims. One of the purposes of a statute of limitations is to put a defendant on notice of the claims against him within the specified period. See, e.g., Order of R.R. Telegraphers v. Railway Express Agency, Inc.,
In Hanna v. Plumer ,
A minority of the federal courts to have considered the issue whether to apply a federal or state equitable tolling rule have done so by weighing the importance of the policy implicated by the federal rule against the importance of the policy of applying the state rule uniformly. See Vaught v. Showa Denko K.K.,
Then-Justice Rehnquist appears to have taken the view that the rule of American Pipe implicitly inhered in Rule 23 in his dissent in Chardon. See Chardon,
We do recognize, however, that the equitable tolling rule established in American Pipe was justified on the basis of many of the same policies that also underlie Rule 23.
